<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
 <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 <link rel="stylesheet" type="text/css" href="savehtml.css"/>
 <title>Adrb1 ---| Heart Failure
 </title>
</head>
<body>
 <div class="props">
  <h1>Regulation Adrb1 ---| Heart Failure</h1>
  <table>
   <tbody>
    <tr>
     <th align="left">URN
     </th>
     <td>urn:agi-Regulation:inout-urn:agi-llid:153:out-urn:agi-meshdis:Heart%20Failure::unknown
     </td>
    </tr>
    <tr>
     <th align="left">References
     </th>
     <td>33
     </td>
    </tr>
    <tr>
     <th align="left">Connectivity
     </th>
     <td>2
     </td>
    </tr>
    <tr>
     <th align="left">Effect
     </th>
     <td>unknown
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The beta-adrenoceptor (beta-AR) plays an important role in heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15592928&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/15592928#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15592928&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15592928:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Beta-adrenergic receptor (betaAR) blockade is a standard therapy for cardiac failure and ischemia.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18425130&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/18425130#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18425130&amp;dopt=AbstractPlus" target="AGI_EXT_REF">18425130:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Desensitisation of cardiac beta-adrenergic receptors may contribute to contractile dysfunction in chronic heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9082678&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/9082678#abs:5
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9082678&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9082678:4
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>These effects may contribute to beta1-adrenoceptor-mediated cardiotoxicity in heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11448139&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/11448139#abs:12
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11448139&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11448139:11
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">CellType
     </th>
     <td>cardiomyocyte
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Carvedilol and metoprolol are beta(1)-adrenoceptor antagonists that decrease mortality in heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=14680448&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/14680448#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=14680448&amp;dopt=AbstractPlus" target="AGI_EXT_REF">14680448:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The catecholamines, via alpha- and beta-adrenergic receptor (beta-AR) stimulation, may play a role in the development of heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12357106&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/12357106#abs:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12357106&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12357106:1
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Beta-1-adrenergic receptor (beta1-AR) blockers reduce both the incidence of sudden death and the ventricular volume in heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12197595&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/12197595#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12197595&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12197595:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In vitro studies have shown down-regulation of beta-AR density in heart failure and cardiac conditions that may lead to heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11807612&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/11807612#abs:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11807612&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11807612:1
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In the right ventricle, beta1-adrenoceptor density decreased only in heart failure; beta2-adrenoceptor density was unchanged.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9456285&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/9456285#abs:8
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9456285&amp;dopt=AbstractPlus" target="AGI_EXT_REF">9456285:7
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>ventricle
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In addition to regulating cardiac rate and contractility, beta1AR and beta2AR may play different roles in the pathogenesis of heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12954981&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/12954981#abs:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12954981&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12954981:1
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Chronic stimulation of the beta(1)-adrenoceptor (beta(1)AR) plays a crucial role in the pathogenesis of heart failure; however, underlying mechanisms remain to be elucidated.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=19103994&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/19103994#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=19103994&amp;dopt=AbstractPlus" target="AGI_EXT_REF">19103994:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Persistent stimulation of cardiac beta1-adrenergic receptors by endogenous norepinephrine promotes heart failure progression.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18947427&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/18947427#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18947427&amp;dopt=AbstractPlus" target="AGI_EXT_REF">18947427:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Exercise performance in patients with congestive heart failure is partially dependent on cardiac beta1-adrenergic receptor (beta1AR) function.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12422153&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/12422153#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12422153&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12422153:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In summary, xamoterol and bucindolol, but not carvedilol and bisoprolol, exhibited direct beta1-adrenoceptor-mediated ISA in normal and heart failure rats.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10086986&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/10086986#abs:10
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10086986&amp;dopt=AbstractPlus" target="AGI_EXT_REF">10086986:9
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Chronic stimulation of the beta(1)-adrenergic receptor leads to hypertrophy and heart failure in beta(1)-adrenergic receptor transgenic mice and contributes to disease progression in heart failure patients.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11964375&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/11964375#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11964375&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11964375:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Numerous studies have demonstrated that beta(1)- and beta(2)-adrenergic receptor gene (ADRB1 and ADRB2) variants influence cardiovascular risk and beta-blocker responses in hypertension and heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18615004&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/18615004#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18615004&amp;dopt=AbstractPlus" target="AGI_EXT_REF">18615004:0
      </a>
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>We have, recently, shown that heart-specific overexpression of the beta(1)-adrenergic receptor in transgenic mice (TG) initially leads to increased contractility, followed by LV hypertrophy and heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12689818&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/12689818#abs:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12689818&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12689818:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Normalization of betaAR signalling consistently ameliorates cardiac dysfunction and survival in heart failure, suggesting that betaAR dysfunction may be intrinsically linked to the deterioration of cardiac performance.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16807128&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/16807128#abs:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16807128&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16807128:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Myocardial beta adrenergic receptor (beta-AR) concentration can substantially decrease in congestive heart failure and significantly increase in chronic volume overload, such as in severe aortic valve regurgitation.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17278500&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/17278500#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17278500&amp;dopt=AbstractPlus" target="AGI_EXT_REF">17278500:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The beta2/beta1 adrenoceptor ratio increases in congestive heart failure (CHF), making the heart relatively more dependent on inotropic, lusitropic, and chronotropic stimulation by the beta2-adrenergic receptor (ADRB2).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17336757&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/17336757#abs:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17336757&amp;dopt=AbstractPlus" target="AGI_EXT_REF">17336757:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>We analyzed the distribution of autoantibodies against Kv channel-interacting protein (KChIP) 2.6, cardiac troponin I (cTnI), and the beta1-adrenergic receptor (second extracellular loop, cardiac beta1-adrenergic receptor [SEL-beta1-AR])-two other known autoantibodies involved in heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18585502&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/18585502#abs:4
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18585502&amp;dopt=AbstractPlus" target="AGI_EXT_REF">18585502:3
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In this review, we attempt to highlight the distinct functionalities and signaling mechanisms of these betaAR subtypes and discuss how these subtype-specific properties of betaARs might affect the pathogenesis of congestive heart failure (CHF) and the therapeutic effectiveness of certain beta-blockers in the treatment of congestive heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15979723&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/15979723#abs:7
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15979723&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15979723:6
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>With the use of delta Vcfc, a load independent parameter of myocardial contraction, AR mediated contraction was evaluated. beta-AR mediated contraction, delta Vcfc by infusion of a beta-AR agonist, isoproterenol, declined with the advancement of heart failure from 0.41 Circ/sec (NYHA I) to 0.31 (NYHA II), 0.22 (NYHA III) and 0.12 (NYHA IV).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1323000&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/1323000#abs:2
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1323000&amp;dopt=AbstractPlus" target="AGI_EXT_REF">1323000:1
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Animals with disruption of PI3K? gene are protected from chronic ß-AR stimulation-induced heart failure ( 33 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17369456&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/17369456#cont:236
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17369456&amp;dopt=AbstractPlus" target="AGI_EXT_REF">17369456:10235
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Heart Circul
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v293 i1 p385
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpheart.physiology.org/cgi/content/full/293/1/H385" target="AGI_EXT_REF">http://ajpheart.physiology.org/cgi/content/full/293/1/H385
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Both apoptosis and ß-AR downregulation are both thought to play a key role in the progression of heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17158652&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/17158652#cont:201
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17158652&amp;dopt=AbstractPlus" target="AGI_EXT_REF">17158652:10200
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Heart Circul
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v292 i4 p1898
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpheart.physiology.org/cgi/content/full/292/4/H1898" target="AGI_EXT_REF">http://ajpheart.physiology.org/cgi/content/full/292/4/H1898
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>These results appear to conflict with observations that betaAR antagonists can reduce fibrosis in heart failure ( 37 , 38 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12711600&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/12711600#cont:271
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12711600&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12711600:10270
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>J. Biol. Chem
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v278 i27 p24461
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.jbc.org/cgi/content/full/278/27/24461" target="AGI_EXT_REF">http://www.jbc.org/cgi/content/full/278/27/24461
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
    <tr>
     <th align="left">CellType
     </th>
     <td>fibroblast
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Moreover, ß-adrenergic receptor (ß-AR) antagonists have been shown to reduce post-MI remodeling and heart failure development and to improve patients&apos; outcome ( 2 , 19 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16699071&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/16699071#cont:22
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16699071&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16699071:10021
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Heart Circul
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v291 i4 p1754
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpheart.physiology.org/cgi/content/full/291/4/H1754" target="AGI_EXT_REF">http://ajpheart.physiology.org/cgi/content/full/291/4/H1754
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>nervous system
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The ßAR antagonist carvedilol recently was demonstrated to significantly reduce morbidity and mortality in heart failure and in post-AMI patients ( 22 – 25 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17925438&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/17925438#cont:24
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17925438&amp;dopt=AbstractPlus" target="AGI_EXT_REF">17925438:10023
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>PNAS
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v104 i42 p16657
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.pnas.org/content/104/42/16657.full" target="AGI_EXT_REF">http://www.pnas.org/content/104/42/16657.full
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">CellLineName
     </th>
     <td>AMI
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In line with this hypothesis, long term treatment with ß-AR antagonists improves prognosis and cardiac function in heart failure patients ( 47 ), whereas ß-AR agonists increase mortality in these patients ( 48 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15569686&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/15569686#cont:262
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15569686&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15569686:10261
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>J. Biol. Chem
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v280 i8 p6906
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.jbc.org/cgi/content/full/280/8/6906" target="AGI_EXT_REF">http://www.jbc.org/cgi/content/full/280/8/6906
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>plasma
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Many clinical trials have indicated that angiotensin-converting enzyme inhibitors and ß-AR blockers significantly improve the survival rates of heart failure patients by decreasing cardiac remodeling ( 8 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16186489&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/16186489#cont:15
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16186489&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16186489:10014
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>PNAS
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v102 i41 p14771
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.pnas.org/cgi/content/full/102/41/14771" target="AGI_EXT_REF">http://www.pnas.org/cgi/content/full/102/41/14771
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The latter authors hypothesized that a 2C - and ß 1 -AR polymorphisms act synergistically to increase synaptic NE release and yield enhanced receptor function, respectively, so as to decrease cardiac function and promote progression of heart failure.
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15001662&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/15001662#cont:225
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15001662&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15001662:10224
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Pharm. Rev
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v56 i1 p31
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://pharmrev.aspetjournals.org/cgi/content/full/56/1/31" target="AGI_EXT_REF">http://pharmrev.aspetjournals.org/cgi/content/full/56/1/31
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">CellLineName
     </th>
     <td>GLY
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Thus, transgenic overexpression of ß 1 -adrenergic receptors in mice leads to cardiac hypertrophy, heart failure, and early death, whereas, overexpression of the ß 2 -adrenergic receptor actually improves cardiac function and does not adversely affect life span (Xiao et al., 1999b ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16204467&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/16204467#cont:131
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16204467&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16204467:10130
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Mol. Pharm
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v69 i1 p5
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://molpharm.aspetjournals.org/cgi/content/full/69/1/5" target="AGI_EXT_REF">http://molpharm.aspetjournals.org/cgi/content/full/69/1/5
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The model of increased cavity volumes studied by us is particularly relevant, as it is well recognized that chronic ß-AR activation occurs in chronic heart failure and contributes to increases in cavity volumes and that ß-AR blocking agents reduce cardiac cavity volumes in chronic heart failure ( 5 , 16 ).
     </td>
    </tr>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15319203&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/15319203#cont:131
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15319203&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15319203:10130
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Heart Circul
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v287 i6 p2762
     </td>
    </tr>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpheart.physiology.org/cgi/content/full/287/6/H2762" target="AGI_EXT_REF">http://ajpheart.physiology.org/cgi/content/full/287/6/H2762
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>heart
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
 </div>
</body>
</html>